Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teresa Binter

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Wiener Klinische Wochenschrift|June 28, 2021
Outcomes of an HCV elimination program targeting the Viennese MSM populationMathias Jachs, Teresa Binter, David Chromy, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 17, 2020
Recent outbreaks of severe hepatitis A virus infections in ViennaDavid Bauer, Anna Farthofer, David Chromy, et al.
Journal of Viral Hepatitis|September 5, 2022
HCV hotline facilitates Hepatitis C elimination during the COVID-19 pandemicLukas Hartl, Mathias Jachs, David Bauer, et al.
Hepatology Communications|July 5, 2021
COVID-19-Related Downscaling of In-Hospital Liver Care Decreased Patient Satisfaction and Increased Liver-Related MortalityLukas Hartl, Georg Semmler, Benedikt Silvester Hofer, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 20, 2021
The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varicesRafael Paternostro, Jeannette Becker, Benedikt Silvester Hofer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 21, 2020
MRI-defined sarcopenia predicts mortality in patients with chronic liver diseaseLucian Beer, Nina Bastati, Ahmed Ba-Ssalamah, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2021
Safety of direct oral anticoagulants in patients with advanced liver diseaseGeorg Semmler, Katharina Pomej, David J M Bauer, et al.
Journal of Personalized Medicine|April 30, 2021
Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVRGeorg Semmler, Teresa Binter, Karin Kozbial, et al.
Infectious Diseases (London, England)|December 9, 2022
Progress of Hepatitis C elimination in Viennese people living with HIV after two decades of increasing cure ratesDavid Chromy, David Bauer, Benedikt Simbrunner, et al.
Alimentary Pharmacology & Therapeutics|May 6, 2022
Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-results of a "real world" studyMathias Jachs, Caroline Schwarz, Marlene Panzer, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Wiener Klinische Wochenschrift|June 28, 2021
Outcomes of an HCV elimination program targeting the Viennese MSM populationMathias Jachs, Teresa Binter, David Chromy, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 17, 2020
Recent outbreaks of severe hepatitis A virus infections in ViennaDavid Bauer, Anna Farthofer, David Chromy, et al.
Journal of Viral Hepatitis|September 5, 2022
HCV hotline facilitates Hepatitis C elimination during the COVID-19 pandemicLukas Hartl, Mathias Jachs, David Bauer, et al.
Hepatology Communications|July 5, 2021
COVID-19-Related Downscaling of In-Hospital Liver Care Decreased Patient Satisfaction and Increased Liver-Related MortalityLukas Hartl, Georg Semmler, Benedikt Silvester Hofer, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 20, 2021
The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varicesRafael Paternostro, Jeannette Becker, Benedikt Silvester Hofer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 21, 2020
MRI-defined sarcopenia predicts mortality in patients with chronic liver diseaseLucian Beer, Nina Bastati, Ahmed Ba-Ssalamah, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2021
Safety of direct oral anticoagulants in patients with advanced liver diseaseGeorg Semmler, Katharina Pomej, David J M Bauer, et al.
Journal of Personalized Medicine|April 30, 2021
Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVRGeorg Semmler, Teresa Binter, Karin Kozbial, et al.
Infectious Diseases (London, England)|December 9, 2022
Progress of Hepatitis C elimination in Viennese people living with HIV after two decades of increasing cure ratesDavid Chromy, David Bauer, Benedikt Simbrunner, et al.
Alimentary Pharmacology & Therapeutics|May 6, 2022
Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-results of a "real world" studyMathias Jachs, Caroline Schwarz, Marlene Panzer, et al.
Pageof 3